Cargando…

Association between the SLC6A11 rs2304725 and GABRG2 rs211037 polymorphisms and drug-resistant epilepsy: a meta-analysis

Background: Previous studies have shown that SLC6A11 and GABRG2 are linked to drug-resistant epilepsy (DRE), although there have been conflicting results in the literature. In this study, we systematically assessed the relationship between DRE and these two genes. Methods: We systematically searched...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xuemei, Zhao, Mingyang, Yang, Xue, Wang, Dongsen, Wu, Qingjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235491/
https://www.ncbi.nlm.nih.gov/pubmed/37275237
http://dx.doi.org/10.3389/fphys.2023.1191927
_version_ 1785052689389846528
author Hu, Xuemei
Zhao, Mingyang
Yang, Xue
Wang, Dongsen
Wu, Qingjian
author_facet Hu, Xuemei
Zhao, Mingyang
Yang, Xue
Wang, Dongsen
Wu, Qingjian
author_sort Hu, Xuemei
collection PubMed
description Background: Previous studies have shown that SLC6A11 and GABRG2 are linked to drug-resistant epilepsy (DRE), although there have been conflicting results in the literature. In this study, we systematically assessed the relationship between DRE and these two genes. Methods: We systematically searched the PubMed, Embase, Cochrane Library, Web of Science, Google Scholar, Wanfang Data, CNKI, and VIP databases. To clarify whether heterogeneity existed between studies, tools such as the Q-test and I ( 2 ) statistic were selected. According to study heterogeneity, we chose fixed- or random-effects models for analysis. We then used the chi-squared ratio to evaluate any bias of the experimental data. Results: In total, 11 trials and 3,813 patients were selected. To investigate the relationship with DRE, we performed model tests on the two genes separately. The results showed that SLC6A11 rs2304725 had no significant correlation with DRE risk in the allele, dominant, recessive, and additive models in a pooled population. However, for the over-dominant model, DRE was correlated with rs2304725 (OR = 1.08, 95% CI: 0.92–1.27, p = 0.33) in a pooled population. Similarly, rs211037 was weakly significantly correlated with DRE for the dominant, recessive, over-dominant, and additive models in a pooled population. The subgroup analysis results showed that rs211037 expressed a genetic risk of DRE in allele (OR = 1.01, 95% CI: 0.76–1.35, p = 0.94), dominant (OR = 1.08, 95% CI: 0.77–1.50, p = 0.65), and additive models (OR = 1.14, 95% CI: 0.62–2.09, p = 0.67) in an Asian population. Conclusion: In this meta-analysis, our results showed that SLC6A11 rs2304725 and GABRG2 rs211037 are not significantly correlated with DRE. However, in the over-dominant model, rs2304725 was significantly correlated with DRE. Likewise, rs211037 conveyed a genetic risk for DRE in an Asian population in the allele, dominant, and additive models.
format Online
Article
Text
id pubmed-10235491
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102354912023-06-03 Association between the SLC6A11 rs2304725 and GABRG2 rs211037 polymorphisms and drug-resistant epilepsy: a meta-analysis Hu, Xuemei Zhao, Mingyang Yang, Xue Wang, Dongsen Wu, Qingjian Front Physiol Physiology Background: Previous studies have shown that SLC6A11 and GABRG2 are linked to drug-resistant epilepsy (DRE), although there have been conflicting results in the literature. In this study, we systematically assessed the relationship between DRE and these two genes. Methods: We systematically searched the PubMed, Embase, Cochrane Library, Web of Science, Google Scholar, Wanfang Data, CNKI, and VIP databases. To clarify whether heterogeneity existed between studies, tools such as the Q-test and I ( 2 ) statistic were selected. According to study heterogeneity, we chose fixed- or random-effects models for analysis. We then used the chi-squared ratio to evaluate any bias of the experimental data. Results: In total, 11 trials and 3,813 patients were selected. To investigate the relationship with DRE, we performed model tests on the two genes separately. The results showed that SLC6A11 rs2304725 had no significant correlation with DRE risk in the allele, dominant, recessive, and additive models in a pooled population. However, for the over-dominant model, DRE was correlated with rs2304725 (OR = 1.08, 95% CI: 0.92–1.27, p = 0.33) in a pooled population. Similarly, rs211037 was weakly significantly correlated with DRE for the dominant, recessive, over-dominant, and additive models in a pooled population. The subgroup analysis results showed that rs211037 expressed a genetic risk of DRE in allele (OR = 1.01, 95% CI: 0.76–1.35, p = 0.94), dominant (OR = 1.08, 95% CI: 0.77–1.50, p = 0.65), and additive models (OR = 1.14, 95% CI: 0.62–2.09, p = 0.67) in an Asian population. Conclusion: In this meta-analysis, our results showed that SLC6A11 rs2304725 and GABRG2 rs211037 are not significantly correlated with DRE. However, in the over-dominant model, rs2304725 was significantly correlated with DRE. Likewise, rs211037 conveyed a genetic risk for DRE in an Asian population in the allele, dominant, and additive models. Frontiers Media S.A. 2023-05-19 /pmc/articles/PMC10235491/ /pubmed/37275237 http://dx.doi.org/10.3389/fphys.2023.1191927 Text en Copyright © 2023 Hu, Zhao, Yang, Wang and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Hu, Xuemei
Zhao, Mingyang
Yang, Xue
Wang, Dongsen
Wu, Qingjian
Association between the SLC6A11 rs2304725 and GABRG2 rs211037 polymorphisms and drug-resistant epilepsy: a meta-analysis
title Association between the SLC6A11 rs2304725 and GABRG2 rs211037 polymorphisms and drug-resistant epilepsy: a meta-analysis
title_full Association between the SLC6A11 rs2304725 and GABRG2 rs211037 polymorphisms and drug-resistant epilepsy: a meta-analysis
title_fullStr Association between the SLC6A11 rs2304725 and GABRG2 rs211037 polymorphisms and drug-resistant epilepsy: a meta-analysis
title_full_unstemmed Association between the SLC6A11 rs2304725 and GABRG2 rs211037 polymorphisms and drug-resistant epilepsy: a meta-analysis
title_short Association between the SLC6A11 rs2304725 and GABRG2 rs211037 polymorphisms and drug-resistant epilepsy: a meta-analysis
title_sort association between the slc6a11 rs2304725 and gabrg2 rs211037 polymorphisms and drug-resistant epilepsy: a meta-analysis
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235491/
https://www.ncbi.nlm.nih.gov/pubmed/37275237
http://dx.doi.org/10.3389/fphys.2023.1191927
work_keys_str_mv AT huxuemei associationbetweentheslc6a11rs2304725andgabrg2rs211037polymorphismsanddrugresistantepilepsyametaanalysis
AT zhaomingyang associationbetweentheslc6a11rs2304725andgabrg2rs211037polymorphismsanddrugresistantepilepsyametaanalysis
AT yangxue associationbetweentheslc6a11rs2304725andgabrg2rs211037polymorphismsanddrugresistantepilepsyametaanalysis
AT wangdongsen associationbetweentheslc6a11rs2304725andgabrg2rs211037polymorphismsanddrugresistantepilepsyametaanalysis
AT wuqingjian associationbetweentheslc6a11rs2304725andgabrg2rs211037polymorphismsanddrugresistantepilepsyametaanalysis